Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lopez-Trabada Ataz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|May 27, 2015
[Nab-paclitaxel]Daniel Lopez-Trabada Ataz, Sarah Dumont, Thierry André
Bulletin Du Cancer|December 29, 2019
[Familial adenomatous polyposis, desmoid tumors and Gardner syndrome]Cherif Tayeb Tayeb, Yann Parc, Thierry Andre, et al.
La Revue Du Praticien|March 15, 2019
[Cardiac and vascular toxicity of chemotherapies]Stéphane Ederhy, Yann Ancedy, Stéphane Champiat, et al.
The Oncologist|July 21, 2019
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort SurveyFlorence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2022
Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)Nicolas Benech, Sylvie Bonvalot, Armelle Dufresne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2023
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized TrialCindy Neuzillet, Olivier Bouché, Christophe Tournigand, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 30, 2022
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancerEmeric Boisteau, Eric François, Thomas Aparicio, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinomaDavid Piquemal, Roman Bruno, Barbara Bournet, et al.
The Lancet. Oncology|March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 studyStefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 22, 2025
Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections)Florent Eymard, Karine Louati, Éric Noel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|May 27, 2015
[Nab-paclitaxel]Daniel Lopez-Trabada Ataz, Sarah Dumont, Thierry André
Bulletin Du Cancer|December 29, 2019
[Familial adenomatous polyposis, desmoid tumors and Gardner syndrome]Cherif Tayeb Tayeb, Yann Parc, Thierry Andre, et al.
La Revue Du Praticien|March 15, 2019
[Cardiac and vascular toxicity of chemotherapies]Stéphane Ederhy, Yann Ancedy, Stéphane Champiat, et al.
The Oncologist|July 21, 2019
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort SurveyFlorence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2022
Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)Nicolas Benech, Sylvie Bonvalot, Armelle Dufresne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2023
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized TrialCindy Neuzillet, Olivier Bouché, Christophe Tournigand, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 30, 2022
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancerEmeric Boisteau, Eric François, Thomas Aparicio, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinomaDavid Piquemal, Roman Bruno, Barbara Bournet, et al.
The Lancet. Oncology|March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 studyStefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 22, 2025
Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections)Florent Eymard, Karine Louati, Éric Noel, et al.
Pageof 1